Results 181 to 190 of about 2,377,916 (241)
Some of the next articles are maybe not open access.
Pharmacogenetics of antiarrhythmic therapy
Expert Opinion on Pharmacotherapy, 2006Individuals vary widely in their responses to therapy with most drugs. Indeed, responses to antiarrhythmic drugs are so highly variable that study of the underlying mechanisms has elucidated important lessons for understanding variable responses to drug therapy in general. Variability in drug response may reflect variability in the relationship between
Dawood Darbar, Dan Roden
exaly +3 more sources
Antiarrhythmic Drug Therapy for Atrial Fibrillation
Cardiology Clinics, 2014Atrial fibrillation (AF) is the most frequently encountered arrhythmia. Prevalence increases with advancing age and so as its associated comorbidities, like heart failure. Choice of pharmacologic therapy depends on whether the goal of treatment is maintaining sinus rhythm or tolerating AF with adequate control of ventricular rates.
Wajeeha Saeed
exaly +4 more sources
Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia. [PDF]
Journal of the American College of Cardiology, 2022 [EN]In patients with ischemic cardiomyopathy and an implantable cardioverter-defibrillator (ICD), catheter ablation and antiarrhythmic drugs (AADs) reduce ICD shocks, but the most effective approach remains uncertain.
Pablo Ávila +2 more
exaly +2 more sources
The implications of antiarrhythmic therapy in aviators.
European Heart Journal, 1988S M Cobbe
exaly +3 more sources
Therapy with Antiarrhythmic Drugs
New England Journal of Medicine, 1978How much of what drug for whom?1 Good habits of mind are encouraged when the physician asks these questions before prescribing a drug.
P, Goldman, J A, Ingelfinger
openaire +2 more sources
Current Treatment Options in Cardiovascular Medicine, 2006
The use of antiarrhythmic drugs can be challenging to physicians. They are effective in treating various types of arrhythmias, yet their potential to cause adverse events, in particularly proarrhythmia, can be intimidating. When the decision to use antiarrhythmic therapy has been made, physicians are confronted with several issues: choosing the right ...
Brian R, Triola, Peter R, Kowey
openaire +2 more sources
The use of antiarrhythmic drugs can be challenging to physicians. They are effective in treating various types of arrhythmias, yet their potential to cause adverse events, in particularly proarrhythmia, can be intimidating. When the decision to use antiarrhythmic therapy has been made, physicians are confronted with several issues: choosing the right ...
Brian R, Triola, Peter R, Kowey
openaire +2 more sources